Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors

NCT00186953 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Abdominal Neoplasms
Pelvic Neoplasms

Interventions

DRUG: Optison

Sponsor

St. Jude Children's Research Hospital